Conferences Novo Nordisk is attending in 2026

LinkedIn novonordisk.com

Novo Nordisk is listed at 5 conferences on Tnuki's calendar in 2026: BioTechX Europe 2026 (exhibiting), ASHG 2026 (on the program), TIDES Europe 2026 (on the program), BIO-Europe 2026 (Gold Sponsor) and ASH 2026 (exhibiting). Novo Nordisk (also known as Novo and Novo Nordisk A/S) is a pharmaceutical company developing medicines for diabetes, obesity, and rare blood and endocrine diseases. As of Sep 29, 2026.

ConferenceDetailsInvolvementTnuki guide
BioTechX Europe 2026European pharma data & informatics leadersOfficial site
Basel, Switzerland ~3k attendees ExhibitorAs published by Terrapinn
Program 6 panel discussions, 6 talks, 1 keynote, 1 session chair
Attending
  • Vice President, Operational Data Insights
  • Lead AI Engineer, AI Reinvent & Engineering
  • Senior Director
  • Scientific Director, Data & AI
  • Associate Director, Product and AI
  • Business Analyst
  • Digital Innovation Lead
  • Head of Digital Biology, Artificial Intelligence & Digital Innovation
  • Principal Data Scientist
Attendee mix: Mostly industry; R&D IT, data science, discovery informatics and clinical data leaders in pharma and biotech
Open the guide Search and filter attendees
ASHG 2026 Annual MeetingGlobal community of human geneticistsOfficial site
Montréal, QC ~7.5k attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 1 poster
Attending
  • Genetics Specialist
  • Scientist
Attendee mix: Mostly academic & clinical; genetics PIs, trainees, lab directors and clinical geneticists
Open the guide Search and filter attendees
TIDES Europe 2026: Oligonucleotide & Peptide TherapeuticsOligonucleotide & peptide drug developersOfficial site
Amsterdam, Netherlands ~900 attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 6 talks, 1 keynote
Attending
  • Scientific Director, Peptide Research 1 
  • Regulatory CMC Specialist
  • Senior Specialist, Analytical Support
  • Director
  • Business Innovation & Partnerships Lead Obesity & GLP-1
  • Scientific Director, Emerging Obesity Mechanism, The Energy Expenditure Group
Attendee mix: Mostly industry; oligonucleotide and peptide R&D scientists, CMC and manufacturing specialists, regulatory and BD
Open the guide Search and filter attendees
BIO-Europe 2026European biotech partnering & BDOfficial site
Cologne, Germany ~5.8k attendees ◇Gold SponsorAs published by EBD Group (Informa)
Program 4 panel discussions
Attending
  • VP Rare Disease & Cell Therapy Business Development, Corporate Development
  • Director Public Private Partnerships
  • Director - Search & Evaluation
  • Global Project Leader
Attendee mix: Almost entirely industry; European biotech and pharma BD executives, licensing teams and investors
Open the guide Search and filter attendees
ASH 2026 Annual Meeting & ExpositionHematologists & blood cancer researchersOfficial site
New Orleans, LA ~30k attendees ExhibitorAs published by American Society of Hematology
Booth 913Program 1 symposium, 1 talk
Attending
  • MD
Attendee mix: Mostly clinical; hematologists, KOLs, hematologic-oncology researchers, medical affairs and cell-therapy biopharma teams
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 29 of the 90 conferences on our calendar, so this page shows Novo Nordisk’s involvement at those 29 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Novo Nordisk

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →